[go: up one dir, main page]

NO20004617D0 - Tablett som disintegrerer hurtig i munnhulen - Google Patents

Tablett som disintegrerer hurtig i munnhulen

Info

Publication number
NO20004617D0
NO20004617D0 NO20004617A NO20004617A NO20004617D0 NO 20004617 D0 NO20004617 D0 NO 20004617D0 NO 20004617 A NO20004617 A NO 20004617A NO 20004617 A NO20004617 A NO 20004617A NO 20004617 D0 NO20004617 D0 NO 20004617D0
Authority
NO
Norway
Prior art keywords
tablet
sugar
present
amorphous
humidified
Prior art date
Application number
NO20004617A
Other languages
English (en)
Other versions
NO20004617L (no
Inventor
Takao Mizumoto
Yoshinori Masuda
Atsushi Kajiyama
Masahiro Yanagisawa
Janaki Ram Nyshadham
Original Assignee
Yamanouchi Pharma Co Ltd
Shaklee Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd, Shaklee Corp filed Critical Yamanouchi Pharma Co Ltd
Publication of NO20004617D0 publication Critical patent/NO20004617D0/no
Publication of NO20004617L publication Critical patent/NO20004617L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L12/00—Data switching networks
    • H04L12/28—Data switching networks characterised by path configuration, e.g. LAN [Local Area Networks] or WAN [Wide Area Networks]
    • H04L12/44—Star or tree networks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/01—Protocols
    • H04L67/12—Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L67/00—Network arrangements or protocols for supporting network services or applications
    • H04L67/50—Network services
    • H04L67/55—Push-based network services
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L9/00—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols
    • H04L9/40—Network security protocols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L69/00—Network arrangements, protocols or services independent of the application payload and not provided for in the other groups of this subclass
    • H04L69/08—Protocols for interworking; Protocol conversion
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L69/00—Network arrangements, protocols or services independent of the application payload and not provided for in the other groups of this subclass
    • H04L69/30—Definitions, standards or architectural aspects of layered protocol stacks
    • H04L69/32—Architecture of open systems interconnection [OSI] 7-layer type protocol stacks, e.g. the interfaces between the data link level and the physical level
    • H04L69/322—Intralayer communication protocols among peer entities or protocol data unit [PDU] definitions
    • H04L69/329—Intralayer communication protocols among peer entities or protocol data unit [PDU] definitions in the application layer [OSI layer 7]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Computing Systems (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Computer Security & Cryptography (AREA)
  • Medicinal Preparation (AREA)
NO20004617A 1998-03-16 2000-09-15 Tablett som disintegrerer hurtig i munnhulen NO20004617L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7876198P 1998-03-16 1998-03-16
PCT/JP1998/004592 WO1999047124A1 (fr) 1998-03-16 1998-10-13 Comprimes a desintegration rapide dans la cavite orale et leur procede de production

Publications (2)

Publication Number Publication Date
NO20004617D0 true NO20004617D0 (no) 2000-09-15
NO20004617L NO20004617L (no) 2000-09-15

Family

ID=22146068

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004617A NO20004617L (no) 1998-03-16 2000-09-15 Tablett som disintegrerer hurtig i munnhulen

Country Status (13)

Country Link
US (3) US6589554B1 (no)
EP (1) EP1072256A4 (no)
JP (1) JP4396033B2 (no)
KR (1) KR100655627B1 (no)
CN (1) CN1196476C (no)
AU (1) AU756488B2 (no)
CA (1) CA2323734C (no)
HU (1) HUP0101282A3 (no)
NO (1) NO20004617L (no)
NZ (1) NZ506903A (no)
PL (1) PL207953B1 (no)
RU (1) RU2204996C2 (no)
WO (1) WO1999047124A1 (no)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4396033B2 (ja) * 1998-03-16 2010-01-13 アステラス製薬株式会社 口腔内速崩壊錠およびその製造法
GB2353933A (en) * 1999-09-09 2001-03-14 British Sugar Plc Compositions comprising trehalose for forming tablets
US7022311B1 (en) * 1999-10-12 2006-04-04 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US6656492B2 (en) 2000-06-30 2003-12-02 Yamanouchi Pharmaceutical Co., Ltd. Quick disintegrating tablet in buccal cavity and manufacturing method thereof
AU2001267865A1 (en) 2000-06-30 2002-01-14 Yamanouchi Pharmaceutical Co..Ltd. Tablet rapidly disintegrating in mouth and process for producing the same
DE60130657T2 (de) 2000-07-20 2008-07-03 Campina Nederland Holding B.V. Methode zur herstellung eines kristallinen tablettierungshilfstoffes, der so erhaltene hilfsstoff und seine verwendung
CA2424770A1 (en) * 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
US6998139B2 (en) * 2001-03-15 2006-02-14 Astellas Pharma Inc. Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
EP1413294B1 (en) * 2001-07-27 2010-09-29 Astellas Pharma Inc. Composition comprising sustained-release fine particles for quick-disintegrating tablets in the buccal cavity
CN100337628C (zh) * 2002-08-07 2007-09-19 王登之 治疗痴呆症的尼莫地平口腔崩解片及其制备方法
AU2003298776A1 (en) * 2002-11-25 2004-06-18 Purdue Research Foundation Mannose-based fast dissolving tablets
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
JP4739217B2 (ja) * 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CA2539445A1 (en) * 2003-09-30 2005-04-07 Snow Brand Milk Products Co., Ltd. Agent for promoting osteogenesis and/or inhibiting bone resorption
KR20050118775A (ko) * 2004-06-15 2005-12-20 주식회사 태평양 당류의 재결정화 및 약물과의 가교형성을 이용한 구강내속붕해정
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
US20100062063A1 (en) 2006-09-15 2010-03-11 Astellas Pharma Inc. Light-stable solid pharmaceutical composition of ramosetron
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
CN101842085B (zh) * 2007-10-31 2013-01-30 麦克内尔-Ppc股份有限公司 口腔崩解剂型
CA2726553A1 (en) 2008-07-08 2010-01-14 Hyperbranch Medical Technology, Inc. Self-contained medical applicators for multiple component formulations, and methods of use thereof
JP5515074B2 (ja) * 2008-12-08 2014-06-11 杏林製薬株式会社 口腔内速崩壊性錠剤
JP5549443B2 (ja) * 2009-07-15 2014-07-16 ライオン株式会社 口腔内崩壊錠及びその製造方法
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
WO2012039788A1 (en) 2010-09-22 2012-03-29 Mcneil-Ppc, Inc. Multi-layered orally disintegrating tablet and the manufacture thereof
US8871263B2 (en) 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
EP2618813A1 (en) 2010-09-22 2013-07-31 McNeil-PPC, Inc. Manufacture of tablets from energy-applied powder blend
FR2970400B1 (fr) 2011-01-19 2013-02-22 Eurotab Procede de fabrication de compacts de lait
KR20130076015A (ko) 2011-12-28 2013-07-08 주식회사 삼양바이오팜 높은 경도를 갖는 속붕정 및 이의 제조 방법
EP2807177B1 (en) 2012-01-27 2019-11-13 The Regents of The University of California Stabilization of biomolecules using sugar polymers
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
KR101352689B1 (ko) * 2012-12-31 2014-01-17 (주) 에프엔지리서치 불연속상과 연속상으로 이루어지는 응집단위를 포함하는 마이크로그래뉼 제형
CN103721265A (zh) * 2013-12-16 2014-04-16 扬子江药业集团广州海瑞药业有限公司 一种枸地氯雷他定的口腔崩解组合物
AU2015204763A1 (en) 2014-01-10 2016-07-21 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
BR112019010785A8 (pt) 2016-11-28 2022-08-09 Currahee Holding Company Inc Processo para produzir uma forma de dosagem revestida
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5119017B2 (no) * 1972-04-12 1976-06-14
PH20837A (en) * 1983-04-29 1987-05-08 Pennwalt Corp Rapid dissolving uniform drug compositon
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
NZ246091A (en) * 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
JPH0948726A (ja) * 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
JP4396033B2 (ja) * 1998-03-16 2010-01-13 アステラス製薬株式会社 口腔内速崩壊錠およびその製造法

Also Published As

Publication number Publication date
US6589554B1 (en) 2003-07-08
CN1286631A (zh) 2001-03-07
US20030203022A1 (en) 2003-10-30
CN1196476C (zh) 2005-04-13
KR20010041894A (ko) 2001-05-25
EP1072256A1 (en) 2001-01-31
CA2323734C (en) 2007-04-17
CA2323734A1 (en) 1999-09-23
JP4396033B2 (ja) 2010-01-13
AU756488B2 (en) 2003-01-16
US20050100598A1 (en) 2005-05-12
EP1072256A4 (en) 2004-03-31
PL342928A1 (en) 2001-07-16
PL207953B1 (pl) 2011-02-28
WO1999047124A1 (fr) 1999-09-23
HUP0101282A3 (en) 2005-03-29
AU9459698A (en) 1999-10-11
KR100655627B1 (ko) 2006-12-12
NZ506903A (en) 2003-01-31
HUP0101282A1 (hu) 2001-08-28
US6803054B2 (en) 2004-10-12
RU2204996C2 (ru) 2003-05-27
NO20004617L (no) 2000-09-15

Similar Documents

Publication Publication Date Title
NO20004617D0 (no) Tablett som disintegrerer hurtig i munnhulen
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
RU2000123778A (ru) Таблетка, быстро распадающаяся в щечном кармане, и способ ее изготовления
RS20050019A (en) Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
ES2086011T3 (es) Chicle farmaceutico con acido acetilsalicilico.
PT1166776E (pt) Processo para a preparacao de formas de apresentacao farmaceutica orais solidas com libertacao retardada da substancia activa
MXPA03007712A (es) Sales farmaceuticas.
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
ATE357148T1 (de) Brausekonfektriegel
WO2008087323A8 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
IL172619A (en) Pharmaceutical formulations comprising (a) levothyroxine sodium, (b) micro crystalline cellulose, and (c) pregelatinised starch, use thereof in the manufacture of medicaments for the treatment of thyroid hormone disorders in a mammal and a process for preparing said pharmaceutical formulations
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
WO2003092655A3 (de) Verwendung von wirkstoffmischungen mit azelainsaure und glycyrrhetinsaure als anti-aknemittel
BR0016942A (pt) Derivados substituìdos de aminometil-fenil-ciclohexano
DK1194042T3 (da) Fremstilling af sukkerfrit, hårdt bolsje
FR2848851B1 (fr) Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
RU99116432A (ru) Способ иммобилизации физиологически активных соединений
WO2004043982A3 (fr) Nouveaux derives amphiphiles de l'alpha-c-phenyl-n-tert-butyl nitrone
FR2780650B1 (fr) Solutions salines, leur procede de preparation et medicaments a base de ces solutions
WO2001070694A8 (en) Amorphous torasemide modification
BR0015877A (pt) Polimorfo v de torasemida
HK1073295A1 (en) Acetyl l-carnitine acid fumarate and process for preparing the same
CA2355779A1 (en) Improved release of medicament active agents from a chewing gum coating

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application